Categories
rss-es

Vyaire Medical Issues Voluntary Correction for Certain bellavista™ Ventilators in Specific Software Configurations

Murilo Freitas - 05:00, 3 de febrero de 2022539
In December 2021, imtmedical ag, a subsidiary of Vyaire Medical, initiated a voluntary field correction for certain bellavista™ ventilators. With specific software version and configuration combinations, the ventilators can cease ventilation and generate a technical failure alarm 305. There is a pot

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/vyaire-medical-issues-voluntary-correction-certain-bellavistatm-ventilators-specific-software

 
Categories
rss-es

Junp LLC Issues Voluntary Nationwide Recall of MegMan Performance Booster Capsules Due to the Presence of Tadalafil

Murilo Freitas - 05:00, 3 de febrero de 2022332
Brooklyn, NY Junp LLC is voluntarily recalling Lot number 2010291, Exp Date: 01/07/2024 of MegMan Performance Booster capsules, packaged in 10-count blisters packaged in a carton to the consumer level. Junp LLC was notified by Amazon that laboratory analysis has found the product to be tainted wit

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/junp-llc-issues-voluntary-nationwide-recall-megman-performance-booster-capsules-due-presence

 
Categories
rss-es

Tercera dosis de vacuna contra COVID-19 puede aplicarse a cinco meses de haber completado esquema

Murilo Freitas - 21:48, 2 de febrero de 2022469

Tercera dosis de vacuna contra COVID-19 puede aplicarse a cinco meses de haber completado esquema

Tercera dosis de vacuna contra COVID-19 puede aplicarse a cinco meses de haber completado esquema3 de febrero de 2020. La Comisión Nacional de Vacunación y Epidemiología (CNVE) aprobó que a partir de hoy se reduzca a cinco…

https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/746-noticias-2021/2267-tercera-dosis-de-vacuna-contra-covid-19-puede-aplicarse-a-cinco-meses-de-haber-completado-esquema

 
Categories
rss rss-es rss-pt

Ukoniq (umbralisib): Drug Safety Communication – FDA Investigating Possible Increased Risk of Death with Lymphoma

Murilo Freitas - 05:00, 2 de febrero de 20222,053
The FDA is investigating a possible increased risk of death with the cancer medicine Ukoniq (umbralisib) approved to treat two specific types of lymphomas, which are cancers that affect the body’s immune system.

http://www.fda.gov/safety/medical-product-safety-information/ukoniq-umbralisib-drug-safety-communication-fda-investigating-possible-increased-risk-death-lymphoma

 
Categories
Inicio Mensajes

Biosimilar and interchangeable biosimilar products – USFDA Curriculum Materials for Health Care Degree Programs

Murilo Freitas - 02:08, 2 de febrero de 20223,321

FDA’s curriculum materials are intended to help educate students in health care professional degree programs, for medicine, nursing, physician assistants, and pharmacy, as well as practicing professionals, to improve understanding of biosimilar and interchangeable biosimilar products and the regulatory approval pathway in the United States.

For more information go to https://www.fda.gov/drugs/biosimilars/curriculum-materials-health-care-degree-programs-biosimilars

 
Categories
rss-es

Casos, hospitalizaciones y fallecimientos COVID-19 continúan registrando alzas

Murilo Freitas - 19:32, 31 de enero de 2022519

Casos, hospitalizaciones y fallecimientos COVID-19 continúan registrando alzas

Casos, hospitalizaciones y fallecimientos COVID-19 continúan registrando alzasMartes 1 de febrero, 2022. La semana epidemiológica 4 que abarcó del 23 al 29 de enero registró 39.611 casos de COVID-19…

https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/746-noticias-2021/2266-casos-hospitalizaciones-y-fallecimientos-covid-19-continuan-registrando-alzas

 
Categories
rss-es

Esupplementsales, LLC Issues a Nationwide Recall All Lots of Hard Dawn Due to the Presence of Undeclared Tadalafil

Murilo Freitas - 05:00, 30 de enero de 2022445
Orangevale, CA, Esupplementsales, LLC is voluntarily recalling lot number 2107 of Hard Dawn Rise and Shine capsules to the consumer level. Esupplementsales, LLC was informed by Amazon that laboratory analysis has found the product to be tainted with tadalafil, an ingredient known as a phosphodieste

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/esupplementsales-llc-issues-nationwide-recall-all-lots-hard-dawn-due-presence-undeclared-tadalafil

 
Categories
rss-es

Esupplementsales, LLC Issues a Nationwide Recall of One Lot of Hard Dawn Due to the Presence of Undeclared Tadalafil

Murilo Freitas - 05:00, 30 de enero de 2022406
Orangevale, CA, Esupplementsales, LLC is voluntarily recalling lot number 2107 of Hard Dawn Rise and Shine capsules to the consumer level. Esupplementsales, LLC was informed by Amazon that laboratory analysis has found the product to be tainted with tadalafil, an ingredient known as a phosphodieste

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/esupplementsales-llc-issues-nationwide-recall-one-lot-hard-dawn-due-presence-undeclared-tadalafil

 
Categories
rss-es

Salud prorroga vigencia de permisos sanitarios de funcionamiento, certificados de habilitación, licencias y autorizaciones

Murilo Freitas - 21:49, 27 de enero de 2022641

Salud prorroga vigencia de permisos sanitarios de funcionamiento, certificados de habilitación, licencias y autorizaciones

Salud prorroga vigencia de permisos sanitarios de funcionamiento, certificados de habilitación, licencias y autorizaciones28 de enero del 2022. Tomando en cuenta la situación epidemiológica que atraviese el país y con objetivo de velar por el bienestar de la población…

https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/746-noticias-2021/2264-salud-prorroga-vigencia-de-permisos-sanitarios-de-funcionamiento-certificados-de-habilitacion-licencias-y-autorizaciones

 
PRAIS 2.0